• Running a Delphi process on autism and addiction: Betul Aslan talks to the SSA
  • What impact does opioid agonist treatment have on mortality at a population level?
  • QMJC June 2022: Timelines and life-grid methods
  • Opioid agonist treatment modelling with Matt Hickman
  • Inside the UK’s first unsanctioned drug consumption room
  • ‘Lena left a big impression on me and my practice as a pharmacist’
  • Can the ‘ageing cohort theory’ account for the increase in drug-related deaths?
  • QMJC May 2022: Investigating the practice of microdosing psychedelics
  • The Gay Men’s Health Collective on chemsex, harm reduction, and cultivating more LGBT+ inclusive drug services
  • Heroin in 1940s America: ‘the work of this era only served to heighten the division between good and bad drugs’